Agenus Reports 72% Pathologic Complete Response in dMMR Colon Cancer Cohort

The 18-patient Phase 2 cohort also met the study’s primary major pathologic response measure in 83% of patients.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.